标题
Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies
作者
关键词
-
出版物
NATURE REVIEWS DRUG DISCOVERY
Volume 15, Issue 4, Pages 249-274
出版商
Springer Nature
发表日期
2016-01-22
DOI
10.1038/nrd.2015.3
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cellular senescence controls fibrosis in wound healing
- (2016) Joon-Il Jun et al. Aging-US
- 2-(3-Benzoylthioureido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylic acid ameliorates metabolic disorders in high-fat diet-fed mice
- (2015) Jin Zhang et al. ACTA PHARMACOLOGICA SINICA
- Proresolving actions of a new resolvin D1 analog mimetic qualifies as an immunoresolvent
- (2015) Sarah K. Orr et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Autophagy in the light of sphingolipid metabolism
- (2015) Eva Bang Harvald et al. APOPTOSIS
- Roles of Acyl-CoA:Diacylglycerol Acyltransferases 1 and 2 in Triacylglycerol Synthesis and Secretion in Primary Hepatocytes
- (2015) C. Li et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Impaired macrophage autophagy increases the immune response in obese mice by promoting proinflammatory macrophage polarization
- (2015) Kun Liu et al. Autophagy
- Extracellular ATP induces P2X7 receptor activation in mouse Kupffer cells, leading to release of IL-1β, HMGB1, and PGE2, decreased MHC class I expression and necrotic cell death
- (2015) Yusuke Toki et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Metabolomic profiling in liver of adiponectin-knockout mice uncovers lysophospholipid metabolism as an important target of adiponectin action
- (2015) Ying Liu et al. BIOCHEMICAL JOURNAL
- 5-Lipoxygenase, a key enzyme for leukotriene biosynthesis in health and disease
- (2015) Olof Rådmark et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- The pharmacology of resveratrol in animals and humans
- (2015) Eun-Jung Park et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Annexin A1 mimetic peptide controls the inflammatory and fibrotic effects of silica particles in mice
- (2015) P G Trentin et al. BRITISH JOURNAL OF PHARMACOLOGY
- Phosphorylation-independent mTORC1 inhibition by the autophagy inducer Rottlerin
- (2015) C. Torricelli et al. CANCER LETTERS
- Anti-Inflammatory and Antiatherogenic Effects of the NLRP3 Inflammasome Inhibitor Arglabin in ApoE2.Ki Mice Fed a High-Fat Diet
- (2015) A. Abderrazak et al. CIRCULATION
- Gut–liver axis, nutrition, and non-alcoholic fatty liver disease
- (2015) Irina A. Kirpich et al. CLINICAL BIOCHEMISTRY
- CXCR3 ligands in disease and therapy
- (2015) Katrien Van Raemdonck et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial
- (2015) Shihui Chen et al. DIGESTIVE AND LIVER DISEASE
- Targeting xenobiotic receptors PXR and CAR in human diseases
- (2015) Monimoy Banerjee et al. DRUG DISCOVERY TODAY
- Central Fibroblast Growth Factor 21 Browns White Fat via Sympathetic Action in Male Mice
- (2015) Nicholas Douris et al. ENDOCRINOLOGY
- Curcumin regulates peroxisome proliferator-activated receptor-γ coactivator-1α expression by AMPK pathway in hepatic stellate cells in vitro
- (2015) Xuguang Zhai et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Saroglitazar for the treatment of dyslipidemia in diabetic patients
- (2015) Shashank R Joshi EXPERT OPINION ON PHARMACOTHERAPY
- Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States
- (2015) Robert J. Wong et al. GASTROENTEROLOGY
- Poster Session 4: Steatohepatitis: Clinical and Therapeutic
- (2015) HEPATOLOGY
- Activation of sphingosine kinase 2 by endoplasmic reticulum stress ameliorates hepatic steatosis and insulin resistance in mice
- (2015) Su-Yeon Lee et al. HEPATOLOGY
- Obeticholic acid and resveratrol in nonalcoholic fatty liver disease: All that is gold does not glitter, not all those who wander are lost
- (2015) Giovanni Musso HEPATOLOGY
- A new mechanism of lipotoxicity: Calcium channel blockers as a treatment for nonalcoholic steatohepatitis?
- (2015) Mark J. Czaja HEPATOLOGY
- ALCAT1 controls mitochondrial etiology of fatty liver diseases, linking defective mitophagy to steatosis
- (2015) Li Wang et al. HEPATOLOGY
- Strategies and endpoints of antifibrotic drug trials: Summary and recommendations from the AASLD Emerging Trends Conference, Chicago, June 2014
- (2015) Natalie J. Torok et al. HEPATOLOGY
- Chemokine and chemokine receptor structure and interactions: implications for therapeutic strategies
- (2015) Irina Kufareva et al. IMMUNOLOGY AND CELL BIOLOGY
- Activation of mTORC1 disrupted LDL receptor pathway: A potential new mechanism for the progression of non-alcoholic fatty liver disease
- (2015) Jing Liu et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Effects of formulation design on niacin therapeutics: mechanism of action, metabolism, and drug delivery
- (2015) Dustin L. Cooper et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- mTOR: a pharmacologic target for autophagy regulation
- (2015) Young Chul Kim et al. JOURNAL OF CLINICAL INVESTIGATION
- Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia: One stone hits two birds
- (2015) Chengfu Xu et al. JOURNAL OF HEPATOLOGY
- Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function
- (2015) Vasundhara Kain et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Endogenous and exogenous mediators of quercetin bioavailability
- (2015) Yi Guo et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Berberine ameliorates nonalcoholic fatty liver disease by a global modulation of hepatic mRNA and lncRNA expression profiles
- (2015) Xinlu Yuan et al. Journal of Translational Medicine
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- Niacin inhibits fat accumulation, oxidative stress, and inflammatory cytokine IL-8 in cultured hepatocytes: Impact on non-alcoholic fatty liver disease
- (2015) Shobha H. Ganji et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Unknown
- (2015) Ilija Jeftic et al. MOLECULAR MEDICINE
- The emerging role of redox-sensitive Nrf2–Keap1 pathway in diabetes
- (2015) Elango Bhakkiyalakshmi et al. PHARMACOLOGICAL RESEARCH
- Cardioprotective potential of annexin-A1 mimetics in myocardial infarction
- (2015) Chengxue Qin et al. PHARMACOLOGY & THERAPEUTICS
- The Dual Role of Nrf2 in Nonalcoholic Fatty Liver Disease: Regulation of Antioxidant Defenses and Hepatic Lipid Metabolism
- (2015) Sílvia S. Chambel et al. Biomed Research International
- Ceramide as a Mediator of Non-Alcoholic Fatty Liver Disease and Associated Atherosclerosis
- (2015) Takhar Kasumov et al. PLoS One
- Galectin-3 induces cell migration via a calcium-sensitive MAPK/ERK1/2 pathway
- (2015) Xiaoge Gao et al. Oncotarget
- Roles of Oxidized Diacylglycerol for Carbon Tetrachloride-induced Liver Injury and Fibrosis in Mouse
- (2014) Susumu Takekoshi et al. ACTA HISTOCHEMICA ET CYTOCHEMICA
- Activation of N-methyl-d-aspartate receptor downregulates inflammasome activity and liver inflammation via a β-arrestin-2 pathway
- (2014) Ahmad Farooq et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Pregnane X receptor activation and silencing promote steatosis of human hepatic cells by distinct lipogenic mechanisms
- (2014) Andreas Bitter et al. ARCHIVES OF TOXICOLOGY
- Suppression of the pro-inflammatory NLRP3/interleukin-1β pathway in macrophages by the thioredoxin reductase inhibitor auranofin
- (2014) Elina Isakov et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Serum acid sphingomyelinase is upregulated in chronic hepatitis C infection and non alcoholic fatty liver disease
- (2014) Georgios Grammatikos et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- AMPK activation prevents excess nutrient-induced hepatic lipid accumulation by inhibiting mTORC1 signaling and endoplasmic reticulum stress response
- (2014) Hongliang Li et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- The anti-fibrotic effects of CCN1/CYR61 in primary portal myofibroblasts are mediated through induction of reactive oxygen species resulting in cellular senescence, apoptosis and attenuated TGF-β signaling
- (2014) Erawan Borkham-Kamphorst et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Discovery of a Novel Class of Diacylglycerol Acyltransferase 2 Inhibitors with a 1H-Pyrrolo[2,3-b]pyridine Core
- (2014) Mun Ock Kim et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Human lysyl oxidase-like 2
- (2014) Hee-Jung Moon et al. BIOORGANIC CHEMISTRY
- Effects of the mTOR inhibitor Rapamycin on Monocyte-Secreted Chemokines
- (2014) Hugo You-Hsien Lin et al. BMC IMMUNOLOGY
- Liver Damage, Inflammation, and Enhanced Tumorigenesis after Persistent mTORC1 Inhibition
- (2014) Atsushi Umemura et al. Cell Metabolism
- Binding Mode and Structure-Activity Relationships around Direct Inhibitors of the Nrf2-Keap1 Complex
- (2014) Eric Jnoff et al. ChemMedChem
- Disruption of Mammalian Target of Rapamycin Complex 1 in Macrophages Decreases Chemokine Gene Expression and Atherosclerosis
- (2014) Ding Ai et al. CIRCULATION RESEARCH
- Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease
- (2014) Veronique S. Chachay et al. Clinical Gastroenterology and Hepatology
- Beyond Bile Acids: Targeting Farnesoid X Receptor (FXR) with Natural and Synthetic Ligands
- (2014) Andrea Carotti et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- FGF21 Maintains Glucose Homeostasis by Mediating the Cross Talk Between Liver and Brain During Prolonged Fasting
- (2014) Q. Liang et al. DIABETES
- Macrophage mTORC1 disruption reduces inflammation and insulin resistance in obese mice
- (2014) Hongfeng Jiang et al. DIABETOLOGIA
- Liver-Enriched Transcription Factor CREBH Interacts With Peroxisome Proliferator-Activated Receptor α to Regulate Metabolic Hormone FGF21
- (2014) Hyunbae Kim et al. ENDOCRINOLOGY
- Gal-3 regulates the capacity of dendritic cells to promote NKT-cell-induced liver injury
- (2014) Vladislav Volarevic et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Discontinued in 2013: diabetic drugs
- (2014) Maka S Hedrington et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- 694 Hepatic CXCR3 Promotes Non-Alcoholic Steatohepatitis Through Inflammation, Lipid Accumulation and Autophagy Deficiency
- (2014) Xiang Zhang et al. GASTROENTEROLOGY
- Fibroblast Growth Factor 21 Limits Lipotoxicity by Promoting Hepatic Fatty Acid Activation in Mice on Methionine and Choline-Deficient Diets
- (2014) Ffolliott M. Fisher et al. GASTROENTEROLOGY
- Galectin-3: an emerging all-out player in metabolic disorders and their complications
- (2014) G. Pugliese et al. GLYCOBIOLOGY
- Galectin-3 regulates hepatic progenitor cell expansion during liver injury
- (2014) Wei-Chen Hsieh et al. GUT
- Fructose leads to hepatic steatosis in zebrafish that is reversed by mechanistic target of rapamycin (mTOR) inhibition
- (2014) Valerie Sapp et al. HEPATOLOGY
- Treatment response in the PIVENS trial is associated with decreased hedgehog pathway activity
- (2014) Cynthia D. Guy et al. HEPATOLOGY
- Endogenous annexin A1 is a novel protective determinant in nonalcoholic steatohepatitis in mice
- (2014) Irene Locatelli et al. HEPATOLOGY
- Pharmacological inhibition of the chemokine C-C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly-6C+macrophage infiltration in mice
- (2014) Christer Baeck et al. HEPATOLOGY
- The transrepressive activity of peroxisome proliferator-activated receptor alpha is necessary and sufficient to prevent liver fibrosis in mice
- (2014) Michal Pawlak et al. HEPATOLOGY
- Maraviroc, a CCR5 antagonist, ameliorates the development of hepatic steatosis in a mouse model of non-alcoholic fatty liver disease (NAFLD)
- (2014) L. Perez-Martinez et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Fibroblast Growth Factor 21 Is Regulated by the IRE1α-XBP1 Branch of the Unfolded Protein Response and Counteracts Endoplasmic Reticulum Stress-induced Hepatic Steatosis
- (2014) Shan Jiang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- TAK1-mediated autophagy and fatty acid oxidation prevent hepatosteatosis and tumorigenesis
- (2014) Sayaka Inokuchi-Shimizu et al. JOURNAL OF CLINICAL INVESTIGATION
- ASMase regulates autophagy and lysosomal membrane permeabilization and its inhibition prevents early stage non-alcoholic steatohepatitis
- (2014) Raquel Fucho et al. JOURNAL OF HEPATOLOGY
- Isoliquiritigenin is a potent inhibitor of NLRP3 inflammasome activation and diet-induced adipose tissue inflammation
- (2014) Hiroe Honda et al. JOURNAL OF LEUKOCYTE BIOLOGY
- PPARδ activation attenuates hepatic steatosis inLdlr−/−mice by enhanced fat oxidation, reduced lipogenesis, and improved insulin sensitivity
- (2014) Lazar A. Bojic et al. JOURNAL OF LIPID RESEARCH
- Cholesterol-lowering drugs cause dissolution of cholesterol crystals and disperse Kupffer cell crown-like structures during resolution of NASH
- (2014) George N. Ioannou et al. JOURNAL OF LIPID RESEARCH
- Quercetin reduces obesity-associated ATM infiltration and inflammation in mice: a mechanism including AMPKα1/SIRT1
- (2014) Jing Dong et al. JOURNAL OF LIPID RESEARCH
- NLRP3 inflammasome activation is required for fibrosis development in NAFLD
- (2014) Alexander Wree et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Hepatoprotective effects of berberine on liver fibrosis via activation of AMP-activated protein kinase
- (2014) Jing Li et al. LIFE SCIENCES
- Both bone marrow-derived and non-bone marrow-derived cells contribute to AIM2 and NLRP3 inflammasome activation in a MyD88-dependent manner in dietary steatohepatitis
- (2014) Timea Csak et al. LIVER INTERNATIONAL
- The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis
- (2014) Fernando J. Barreyro et al. LIVER INTERNATIONAL
- Susceptibility of Nrf2-Null Mice to Steatohepatitis and Cirrhosis upon Consumption of a High-Fat Diet Is Associated with Oxidative Stress, Perturbation of the Unfolded Protein Response, and Disturbance in the Expression of Metabolic Enzymes but Not with Insulin Resistance
- (2014) P. J. Meakin et al. MOLECULAR AND CELLULAR BIOLOGY
- Resolvin D1 reduces ER stress-induced apoptosis and triglyceride accumulation through JNK pathway in HepG2 cells
- (2014) Tae Woo Jung et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Enhancing the Delivery of Resveratrol in Humans: If Low Bioavailability is the Problem, What is the Solution?
- (2014) James Smoliga et al. MOLECULES
- Effects and mechanisms of resveratrol on the amelioration of oxidative stress and hepatic steatosis in KKAy mice
- (2014) Wei Zhu et al. Nutrition & Metabolism
- Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease
- (2014) Forouzan Faghihzadeh et al. NUTRITION RESEARCH
- Serum Oxidative Stress Markers and Lipidomic Profile to Detect NASH Patients Responsive to an Antioxidant Treatment: A Pilot Study
- (2014) Paola Stiuso et al. Oxidative Medicine and Cellular Longevity
- Structure of the BTB Domain of Keap1 and Its Interaction with the Triterpenoid Antagonist CDDO
- (2014) Anne Cleasby et al. PLoS One
- Inflammatory Stress Increases Hepatic CD36 Translational Efficiency via Activation of the mTOR Signalling Pathway
- (2014) Chuan Wang et al. PLoS One
- Fibroblast Growth Factor 21 Improves Insulin Sensitivity and Synergizes with Insulin in Human Adipose Stem Cell-Derived (hASC) Adipocytes
- (2014) Darwin V. Lee et al. PLoS One
- Pharmacological Inhibition of the Chemokine CXCL16 Diminishes Liver Macrophage Infiltration and Steatohepatitis in Chronic Hepatic Injury
- (2014) Alexander Wehr et al. PLoS One
- Ceramide: A simple sphingolipid with unique biophysical properties
- (2014) Bruno M. Castro et al. PROGRESS IN LIPID RESEARCH
- Mangiferin treatment inhibits hepatic expression of acyl-coenzyme A:diacylglycerol acyltransferase-2 in fructose-fed spontaneously hypertensive rats: a link to amelioration of fatty liver
- (2014) Xiaomang Xing et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- GW4064, a farnesoid X receptor agonist, upregulates adipokine expression in preadipocytes and HepG2 cells
- (2014) Xiao-Min Xin WORLD JOURNAL OF GASTROENTEROLOGY
- Hepatic inflammation and progressive liver fibrosis in chronic liver disease
- (2014) Albert J Czaja WORLD JOURNAL OF GASTROENTEROLOGY
- Impaired autophagic flux is associated with increased endoplasmic reticulum stress during the development of NAFLD
- (2014) Á González-Rodríguez et al. Cell Death & Disease
- Induction of ER stress-mediated apoptosis by ceramide via disruption of ER Ca2+ homeostasis in human adenoid cystic carcinoma cells
- (2014) Zhe Liu et al. Cell and Bioscience
- Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis
- (2014) Giovanni Musso et al. PLOS MEDICINE
- Inhibition of acid sphingomyelinase by tricyclic antidepressants and analogons
- (2014) Nadine Beckmann et al. Frontiers in Physiology
- Hepatic stellate cells and portal fibroblasts are the major cellular sources of collagens and lysyl oxidases in normal liver and early after injury
- (2013) Maryna Perepelyuk et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease
- (2013) Shobha H. Ganji et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- hnRNP K suppresses apoptosis independent of p53 status by maintaining high levels of endogenous caspase inhibitors
- (2013) Ziwei Xiao et al. CARCINOGENESIS
- Activation of mTOR modulates SREBP-2 to induce foam cell formation through increased retinoblastoma protein phosphorylation
- (2013) K. L. Ma et al. CARDIOVASCULAR RESEARCH
- The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes
- (2013) Gregory Gaich et al. Cell Metabolism
- Profibrotic effect of miR-33a with Akt activation in hepatic stellate cells
- (2013) Zhuo-Jian Li et al. CELLULAR SIGNALLING
- Galectin-3 Deficiency Accelerates High-Fat Diet-Induced Obesity and Amplifies Inflammation in Adipose Tissue and Pancreatic Islets
- (2013) N. N. Pejnovic et al. DIABETES
- Roles of Chemokine Ligand-2 (CXCL2) and Neutrophils in Influencing Endothelial Cell Function and Inflammation of Human Adipose Tissue
- (2013) Christine Rouault et al. ENDOCRINOLOGY
- Resolvin D1 primes the resolution process initiated by calorie restriction in obesity-induced steatohepatitis
- (2013) Bibiana Rius et al. FASEB JOURNAL
- Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice
- (2013) Wei-Hsuan Hsu et al. FOOD AND CHEMICAL TOXICOLOGY
- Resveratrol modulates autophagy and NF-κB activity in a murine model for treating non-alcoholic fatty liver disease
- (2013) Lake Li et al. FOOD AND CHEMICAL TOXICOLOGY
- Hepatic SIRT1 Attenuates Hepatic Steatosis and Controls Energy Balance in Mice by Inducing Fibroblast Growth Factor 21
- (2013) Yu Li et al. GASTROENTEROLOGY
- Hepatocyte caspase-8 is an essential modulator of steatohepatitis in rodents
- (2013) Maximilian Hatting et al. HEPATOLOGY
- C-C motif chemokine receptor 9 positive macrophages activate hepatic stellate cells and promote liver fibrosis in mice
- (2013) Po-sung Chu et al. HEPATOLOGY
- Chemokine receptor CCR6-dependent accumulation of γδ T cells in injured liver restricts hepatic inflammation and fibrosis
- (2013) Linda Hammerich et al. HEPATOLOGY
- Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
- (2013) Bart Staels et al. HEPATOLOGY
- Hepatic cannabinoid-1 receptors mediate diet-induced insulin resistance by increasingde novosynthesis of long-chain ceramides
- (2013) Resat Cinar et al. HEPATOLOGY
- Free cholesterol accumulation in hepatic stellate cells: Mechanism of liver fibrosis aggravation in nonalcoholic steatohepatitis in mice
- (2013) Kengo Tomita et al. HEPATOLOGY
- Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma
- (2013) Bryan C. Fuchs et al. HEPATOLOGY
- Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 Diabetes
- (2013) Andreas L. Birkenfeld et al. HEPATOLOGY
- NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice
- (2013) Alexander Wree et al. HEPATOLOGY
- The effects of 30 days resveratrol supplementation on adipose tissue morphology and gene expression patterns in obese men
- (2013) E Konings et al. INTERNATIONAL JOURNAL OF OBESITY
- Trafficking of the Transcription Factor Nrf2 to Promyelocytic Leukemia-Nuclear Bodies
- (2013) Melanie Theodore Malloy et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MCF-7 Cells Expressing Nuclear Associated Lysyl Oxidase-like 2 (LOXL2) Exhibit an Epithelial-to-Mesenchymal Transition (EMT) Phenotype and Are Highly Invasivein Vitro
- (2013) Hee-Jung Moon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- 1319 SIMTUZUMAB, AN ANTIFIBROTIC MONOCLONAL ANTIBODY AGAINST LYSYL OXIDASE-LIKE 2 (LOXL2) ENZYME, APPEARS SAFE AND WELL TOLERATED IN PATIENTS WITH LIVER DISEASE OF DIVERSE ETIOLOGY
- (2013) A.H. Talal et al. JOURNAL OF HEPATOLOGY
- Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation
- (2013) David Castaño et al. JOURNAL OF HEPATOLOGY
- Proresolving and Tissue-Protective Actions of Annexin A1-Based Cleavage-Resistant Peptides Are Mediated by Formyl Peptide Receptor 2/Lipoxin A4 Receptor
- (2013) J. Dalli et al. JOURNAL OF IMMUNOLOGY
- Chemokine Receptor CXCR6-Dependent Hepatic NK T Cell Accumulation Promotes Inflammation and Liver Fibrosis
- (2013) A. Wehr et al. JOURNAL OF IMMUNOLOGY
- Chronic supplementation of proanthocyanidins reduces postprandial lipemia and liver miR-33a and miR-122 levels in a dose-dependent manner in healthy rats
- (2013) Laura Baselga-Escudero et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Nrf2 deletion causes “benign” simple steatosis to develop into nonalcoholic steatohepatitis in mice fed a high-fat diet
- (2013) Chunhua Wang et al. Lipids in Health and Disease
- Inhibition of ceramidede novosynthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease
- (2013) Krzysztof Kurek et al. LIVER INTERNATIONAL
- Matricellular Protein CCN1 Promotes Regression of Liver Fibrosis through Induction of Cellular Senescence in Hepatic Myofibroblasts
- (2013) K.-H. Kim et al. MOLECULAR AND CELLULAR BIOLOGY
- Resveratrol and EGCG bind directly and distinctively to miR-33a and miR-122 and modulate divergently their levels in hepatic cells
- (2013) L. Baselga-Escudero et al. NUCLEIC ACIDS RESEARCH
- Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation
- (2013) João Marcus Oliveira Andrade et al. NUTRITION
- Identification of Three Novel Natural Product Compounds that Activate PXR and CAR and Inhibit Inflammation
- (2013) Suticha Kittayaruksakul et al. PHARMACEUTICAL RESEARCH
- Nanomedicines of Hedgehog Inhibitor and PPAR-γ Agonist for Treating Liver Fibrosis
- (2013) Virender Kumar et al. PHARMACEUTICAL RESEARCH
- PKCδ as a Regulator for TGFβ1-Induced α-SMA Production in a Murine Nonalcoholic Steatohepatitis Model
- (2013) Su Jin Lee et al. PLoS One
- Quercetin Induces Hepatic Lipid Omega-Oxidation and Lowers Serum Lipid Levels in Mice
- (2013) Elise F. Hoek-van den Hil et al. PLoS One
- Increased Adiposity, Dysregulated Glucose Metabolism and Systemic Inflammation in Galectin-3 KO Mice
- (2013) Jingbo Pang et al. PLoS One
- Caspase-1 as a Central Regulator of High Fat Diet-Induced Non-Alcoholic Steatohepatitis
- (2013) Laura J. Dixon et al. PLoS One
- LY2405319, an Engineered FGF21 Variant, Improves the Metabolic Status of Diabetic Monkeys
- (2013) Andrew C. Adams et al. PLoS One
- Vismodegib Suppresses TRAIL-mediated Liver Injury in a Mouse Model of Nonalcoholic Steatohepatitis
- (2013) Petra Hirsova et al. PLoS One
- Therapy of Experimental NASH and Fibrosis with Galectin Inhibitors
- (2013) Peter G. Traber et al. PLoS One
- Regression of Fibrosis and Reversal of Cirrhosis in Rats by Galectin Inhibitors in Thioacetamide-Induced Liver Disease
- (2013) Peter G. Traber et al. PLoS One
- Increased Adiposity in Annexin A1-Deficient Mice
- (2013) Rand T. Akasheh et al. PLoS One
- Development and in vivo efficacy of targeted polymeric inflammation-resolving nanoparticles
- (2013) N. Kamaly et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interactions between Human Liver Fatty Acid Binding Protein and Peroxisome Proliferator Activated Receptor Selective Drugs
- (2013) Tony Velkov PPAR Research
- Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2
- (2012) Kouichi Miura et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Myeloid Deletion of Nuclear Factor Erythroid 2−Related Factor 2 Increases Atherosclerosis and Liver Injury
- (2012) Alan R. Collins et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Differential effects of low-dose resveratrol on adiposity and hepatic steatosis in diet-induced obese mice
- (2012) Su-Jung Cho et al. BRITISH JOURNAL OF NUTRITION
- Mir-33 regulates cell proliferation and cell cycle progression
- (2012) Daniel Cirera-Salinas et al. CELL CYCLE
- Increased Hepatic Synthesis and Dysregulation of Cholesterol Metabolism Is Associated with the Severity of Nonalcoholic Fatty Liver Disease
- (2012) Hae-Ki Min et al. Cell Metabolism
- High-Dose Resveratrol Supplementation in Obese Men: An Investigator-Initiated, Randomized, Placebo-Controlled Clinical Trial of Substrate Metabolism, Insulin Sensitivity, and Body Composition
- (2012) M. M. Poulsen et al. DIABETES
- Sterol Regulatory Element-Binding Factor 2 (SREBF-2) Predicts 7-Year NAFLD Incidence and Severity of Liver Disease and Lipoprotein and Glucose Dysmetabolism
- (2012) G. Musso et al. DIABETES
- Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials
- (2012) G. Musso et al. DIABETOLOGIA
- The Sphingosine-1-Phosphate Analog FTY720 Reduces Muscle Ceramide Content and Improves Glucose Tolerance in High Fat-Fed Male Mice
- (2012) Clinton R. Bruce et al. ENDOCRINOLOGY
- Attenuation of plasma annexin A1 in human obesity
- (2012) Anna Kosicka et al. FASEB JOURNAL
- Dietary quercetin ameliorates nonalcoholic steatohepatitis induced by a high-fat diet in gerbils
- (2012) Hua-Zhong Ying et al. FOOD AND CHEMICAL TOXICOLOGY
- The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
- (2012) Naga Chalasani et al. HEPATOLOGY
- Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice
- (2012) Kouichi Miura et al. HEPATOLOGY
- Peroxisome Proliferator-activated Receptor α Positively Regulates Complement C3 Expression but Inhibits Tumor Necrosis Factor α-mediated Activation ofC3Gene in Mammalian Hepatic-derived Cells
- (2012) Denis A. Mogilenko et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification of Akt-independent Regulation of Hepatic Lipogenesis by Mammalian Target of Rapamycin (mTOR) Complex 2
- (2012) Minsheng Yuan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Kuppfer Cells Trigger Nonalcoholic Steatohepatitis Development in Diet-induced Mouse Model through Tumor Necrosis Factor-α Production
- (2012) Annie-Carole Tosello-Trampont et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Annexin A1, formyl peptide receptor, and NOX1 orchestrate epithelial repair
- (2012) Giovanna Leoni et al. JOURNAL OF CLINICAL INVESTIGATION
- Resolvin D1 and Resolvin D2 Govern Local Inflammatory Tone in Obese Fat
- (2012) J. Claria et al. JOURNAL OF IMMUNOLOGY
- Expression analysis of inflammasomes in experimental models of inflammatory and fibrotic liver disease
- (2012) Sorina Georgiana Boaru et al. Journal of Inflammation-London
- Annexin A1 modulates natural and glucocorticoid-induced resolution of inflammation by enhancing neutrophil apoptosis
- (2012) Juliana P. Vago et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Quercetin Ameliorates Cardiovascular, Hepatic, and Metabolic Changes in Diet-Induced Metabolic Syndrome in Rats
- (2012) Sunil K. Panchal et al. JOURNAL OF NUTRITION
- Carbon tetrachloride-induced hepatic injury through formation of oxidized diacylglycerol and activation of the PKC/NF-κB pathway
- (2012) Kentaro Toriumi et al. LABORATORY INVESTIGATION
- Discovery of indolyl acrylamide derivatives as human diacylglycerol acyltransferase-2 selective inhibitors
- (2012) Kyeong Lee et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Attenuation of insulin resistance, metabolic syndrome and hepatic oxidative stress by resveratrol in fructose-fed rats
- (2012) Pankaj K. Bagul et al. PHARMACOLOGICAL RESEARCH
- Fundamentals of FGF19 & FGF21 Action In Vitro and In Vivo
- (2012) Andrew C. Adams et al. PLoS One
- Rationale-Based Engineering of a Potent Long-Acting FGF21 Analog for the Treatment of Type 2 Diabetes
- (2012) Randy Hecht et al. PLoS One
- Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis
- (2012) T. Kisseleva et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis
- (2012) Giovanni Musso et al. PROGRESS IN LIPID RESEARCH
- Treating Diabetes and Obesity with an FGF21-Mimetic Antibody Activating the Klotho/FGFR1c Receptor Complex
- (2012) I. N. Foltz et al. Science Translational Medicine
- Acetylation of pregnane X receptor protein determines selective function independent of ligand activation
- (2011) Arunima Biswas et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Role of S6K1 in regulation of SREBP1c expression in the liver
- (2011) Shuying Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress
- (2011) S. Gómez-Zorita et al. BRITISH JOURNAL OF NUTRITION
- mTOR Complex 1 Regulates Lipin 1 Localization to Control the SREBP Pathway
- (2011) Timothy R. Peterson et al. CELL
- Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans
- (2011) Silvie Timmers et al. Cell Metabolism
- Regulation of Lipid Homeostasis by the Bifunctional SREBF2-miR33a Locus
- (2011) Guido T. Bommer et al. Cell Metabolism
- Increased Macrophage Migration Into Adipose Tissue in Obese Mice
- (2011) D. Y. Oh et al. DIABETES
- Sulforaphane attenuates hepatic fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-β/Smad signaling
- (2011) Chang Joo Oh et al. FREE RADICAL BIOLOGY AND MEDICINE
- A phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitis
- (2011) Vlad Ratziu et al. HEPATOLOGY
- S6 kinase 2 deficiency enhances ketone body production and increases peroxisome proliferator-activated receptor alpha activity in the liver
- (2011) KyeongJin Kim et al. HEPATOLOGY
- MBX-8025, A Novel Peroxisome Proliferator Receptor-δ Agonist: Lipid and Other Metabolic Effects in Dyslipidemic Overweight Patients Treated with and without Atorvastatin
- (2011) Harold E. Bays et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid–induced ceramide biosynthesis in mice
- (2011) William L. Holland et al. JOURNAL OF CLINICAL INVESTIGATION
- DGAT enzymes are required for triacylglycerol synthesis and lipid droplets in adipocytes
- (2011) Charles A. Harris et al. JOURNAL OF LIPID RESEARCH
- The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
- (2011) Bolormaa Vandanmagsar et al. NATURE MEDICINE
- The Human Serum Metabolome
- (2011) Nikolaos Psychogios et al. PLoS One
- Increased Diacylglycerols Characterize Hepatic Lipid Changes in Progression of Human Nonalcoholic Fatty Liver Disease; Comparison to a Murine Model
- (2011) D. Lee Gorden et al. PLoS One
- Hedgehog Signaling Antagonist Promotes Regression of Both Liver Fibrosis and Hepatocellular Carcinoma in a Murine Model of Primary Liver Cancer
- (2011) George M. Philips et al. PLoS One
- miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling
- (2011) A. Davalos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hepatic insulin resistance in mice with hepatic overexpression of diacylglycerol acyltransferase 2
- (2011) F. R. Jornayvaz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A tea catechin, epigallocatechin-3-gallate, is a unique modulator of the farnesoid X receptor
- (2011) Guodong Li et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Acidic Sphingomyelinase Controls Hepatic Stellate Cell Activation and in Vivo Liver Fibrogenesis
- (2010) Anna Moles et al. AMERICAN JOURNAL OF PATHOLOGY
- Emerging Molecular Targets for the Treatment of Nonalcoholic Fatty Liver Disease
- (2010) Giovanni Musso et al. Annual Review of Medicine
- Fat Cell-Specific Ablation of Rictor in Mice Impairs Insulin-Regulated Fat Cell and Whole-Body Glucose and Lipid Metabolism
- (2010) A. Kumar et al. DIABETES
- C-C Chemokine Receptor 2 (CCR2) Regulates the Hepatic Recruitment of Myeloid Cells That Promote Obesity-Induced Hepatic Steatosis
- (2010) A. E. Obstfeld et al. DIABETES
- Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State
- (2010) f. M. Fisher et al. DIABETES
- Oltipraz upregulates the nuclear respiratory factor 2 alpha subunit (NRF2) antioxidant system and prevents insulin resistance and obesity induced by a high-fat diet in C57BL/6J mice
- (2010) Z. Yu et al. DIABETOLOGIA
- Diversity in Antioxidant Response Enzymes in Progressive Stages of Human Nonalcoholic Fatty Liver Disease
- (2010) R. N. Hardwick et al. DRUG METABOLISM AND DISPOSITION
- Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease
- (2010) Wing-Kin Syn et al. HEPATOLOGY
- Activation of Rac1 promotes hedgehog-mediated acquisition of the myofibroblastic phenotype in rat and human hepatic stellate cells
- (2010) Steve S. Choi et al. HEPATOLOGY
- The fractalkine receptor CX3CR1 protects against liver fibrosis by controlling differentiation and survival of infiltrating hepatic monocytes
- (2010) Karlin Raja Karlmark et al. HEPATOLOGY
- Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice
- (2010) Marie-Luise Berres et al. JOURNAL OF CLINICAL INVESTIGATION
- Galectin-3 ablation protects mice from diet-induced NASH: A major scavenging role for galectin-3 in liver
- (2010) Carla Iacobini et al. JOURNAL OF HEPATOLOGY
- 5-Lipoxygenase Activating Protein Signals Adipose Tissue Inflammation and Lipid Dysfunction in Experimental Obesity
- (2010) R. Horrillo et al. JOURNAL OF IMMUNOLOGY
- mTORC1 controls fasting-induced ketogenesis and its modulation by ageing
- (2010) Shomit Sengupta et al. NATURE
- Allosteric inhibition of lysyl oxidase–like-2 impedes the development of a pathologic microenvironment
- (2010) Vivian Barry-Hamilton et al. NATURE MEDICINE
- Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin
- (2010) William L Holland et al. NATURE MEDICINE
- Resolvin D1 binds human phagocytes with evidence for proresolving receptors
- (2010) S. Krishnamoorthy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK–SIRT1–PGC-1α pathway
- (2010) Mary D. L. Chau et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Accelerated Lipid-Induced Atherogenesis in Galectin-3-Deficient Mice
- (2009) Carla Iacobini et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Depletion of Liver Kupffer Cells Prevents the Development of Diet-Induced Hepatic Steatosis and Insulin Resistance
- (2009) W. Huang et al. DIABETES
- Curcumin Inhibitssrebp-2Expression in Activated Hepatic Stellate Cellsin Vitroby Reducing the Activity of Specificity Protein-1
- (2009) Qiaohua Kang et al. ENDOCRINOLOGY
- PPARδ ligand L-165041 ameliorates Western diet-induced hepatic lipid accumulation and inflammation in LDLR−/− mice
- (2009) Hyun-Joung Lim et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- A novel pregnane X receptor and S14-mediated lipogenic pathway in human hepatocyte
- (2009) Amélie Moreau et al. HEPATOLOGY
- Hepatic recruitment of the inflammatory Gr1+monocyte subset upon liver injury promotes hepatic fibrosis
- (2009) Karlin Raja Karlmark et al. HEPATOLOGY
- 5-lipoxygenase deficiency reduces hepatic inflammation and tumor necrosis factor α-induced hepatocyte damage in hyperlipidemia-prone ApoE-null mice
- (2009) Marcos Martínez-Clemente et al. HEPATOLOGY
- Advanced lipoxidation end‐products mediate lipid‐induced glomerular injury: role of receptor‐mediated mechanisms
- (2009) Carla Iacobini et al. JOURNAL OF PATHOLOGY
- The protective role of pregnane X receptor in lipopolysaccharide/D-galactosamine-induced acute liver injury
- (2009) Kun Wang et al. LABORATORY INVESTIGATION
- Activation of the Nuclear Receptor PXR Decreases Plasma LDL-Cholesterol Levels and Induces Hepatic Steatosis in LDL Receptor Knockout Mice
- (2009) Menno Hoekstra et al. MOLECULAR PHARMACEUTICS
- The nuclear receptor PXR gene variants are associated with liver injury in nonalcoholic fatty liver disease
- (2009) Silvia Sookoian et al. Pharmacogenetics and Genomics
- Increased Expression and Activity of the Transcription Factor FOXO1 in Nonalcoholic Steatohepatitis
- (2008) L. Valenti et al. DIABETES
- Monocyte Chemoattractant Protein-1 Deficiency Fails to Restrain Macrophage Infiltration Into Adipose Tissue
- (2008) E. A. Kirk et al. DIABETES
- Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice
- (2008) J. Xu et al. DIABETES
- Systemic and Distal Repercussions of Liver-Specific Peroxisome Proliferator-Activated Receptor-α Control of the Acute-Phase Response
- (2008) Roxane M. Mansouri et al. ENDOCRINOLOGY
- Farnesoid X receptor antagonizes nuclear factor κB in hepatic inflammatory response
- (2008) Yan-Dong Wang et al. HEPATOLOGY
- Farnesoid X Receptor Deficiency Induces Nonalcoholic Steatohepatitis in Low-Density Lipoprotein Receptor-Knockout Mice Fed a High-Fat Diet
- (2008) B. Kong et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
- (2008) Dana M. Gwinn et al. MOLECULAR CELL
- Hepatic Fatty Acid Transporter Cd36 Is a Common Target of LXR, PXR, and PPARγ in Promoting Steatosis
- (2007) Jie Zhou et al. GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started